miércoles, 25 de octubre de 2023

Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(23)00243-1/fulltext?dgcid=hubspot_update_feature_updatealerts_langas&utm_campaign=update-langas&utm_medium=email&_hsmi=279662021&_hsenc=p2ANqtz-_iZzZUd1QGaR7YW0vR8bVhcMLICwp1g3zOVJUq-QusinnZub5wpG8tHtIxWOUVIYSGAqb1MunrzrWun4V4odY6Af-Yyw&utm_content=279615079&utm_source=hs_email

No hay comentarios:

Publicar un comentario